美国 · SEC FORM 4
Clene Inc.
CLNN · Nasdaq · CIK 0001822791 · Healthcare · Packaged Foods
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
10 同一窗口内观察到的 Form 4 交易行
7 sales · 3 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-01-13 · MATLIN DAVID J.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 880,688
- 上期报告
- 915,634
- 日均成交量
- 117,415
- 回补天数
- 7.5
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-01-13 | MATLIN DAVID J | 买入 (P) | common stock | 33,333 | USD 6.50 | USD 216,664 | SEC 申报 ↗ |
| 2024-09-30 | MATLIN DAVID J | 买入 (P) | Common Stock | 92,307 | USD 4.75 | USD 438,458 | SEC 申报 ↗ |
| 2024-09-30 | Mortenson Mark | 买入 (P) | Common Stock | 20,512 | USD 4.75 | USD 97,432 | SEC 申报 ↗ |
| 2024-09-30 | Etherington Robert Dee | 买入 (P) | Common Stock | 10,000 | USD 4.75 | USD 47,500 | SEC 申报 ↗ |
| 2023-11-10 | MATLIN DAVID J | 买入 (P) | Common Stock | 250,002 | USD 0.41 | USD 102,501 | SEC 申报 ↗ |
| 2023-06-26 | Stevens John Henry | 买入 (P) | Common Stock | 316,455 | USD 0.80 | USD 253,164 | SEC 申报 ↗ |
| 2023-06-26 | Etherington Robert Dee | 买入 (P) | Common Stock | 25,000 | USD 0.81 | USD 20,250 | SEC 申报 ↗ |
| 2023-06-16 | Ugwumba Chidozie | 买入 (P) | Common Stock | 7,500,000 | USD 0.80 | USD 6,000,000 | SEC 申报 ↗ |
| 2023-06-16 | Mosca Alison | 买入 (P) | Common Stock | 2,394,375 | USD 0.80 | USD 1,915,500 | SEC 申报 ↗ |
| 2023-06-16 | MATLIN DAVID J | 买入 (P) | Common Stock | 1,500,000 | USD 0.80 | USD 1,200,000 | SEC 申报 ↗ |
| 2023-06-16 | Gay Jonathon | 买入 (P) | Common Stock | 105,625 | USD 0.80 | USD 84,500 | SEC 申报 ↗ |
| 2022-11-02 | Ugwumba Chidozie | 买入 (P) | Common Stock | 990,099 | USD 1.01 | USD 1,000,000 | SEC 申报 ↗ |
| 2022-11-02 | Stevens John Henry | 买入 (P) | Common Stock | 148,515 | USD 1.01 | USD 150,000 | SEC 申报 ↗ |
| 2022-11-02 | Mosca Alison | 买入 (P) | Common Stock | 792,079 | USD 1.01 | USD 800,000 | SEC 申报 ↗ |
| 2022-11-02 | MATLIN DAVID J | 买入 (P) | Common Stock | 2,871,287 | USD 1.01 | USD 2,900,000 | SEC 申报 ↗ |
Form 4 申报证据
69 transaction lines in the latest 365-day window; 152 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Mosca Alison | 奖励/授予 (A) | common stock | 198,171 | USD 3.28 | USD 650,001 | SEC 申报 ↗ |
| 2026-09-16 | MATLIN DAVID J | 奖励/授予 (A) | common stock | 434,451 | USD 3.28 | USD 1,424,999 | SEC 申报 ↗ |
| 2026-09-16 | Etherington Robert Dee | 奖励/授予 (A) | common stock | 15,244 | USD 3.28 | USD 50,000 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Mosca Alison | 奖励/授予 (A) | common stock | 198,171 | USD 3.28 | USD 650,001 | SEC 申报 ↗ |
| 2026-09-16 | MATLIN DAVID J | 奖励/授予 (A) | common stock | 434,451 | USD 3.28 | USD 1,424,999 | SEC 申报 ↗ |
| 2026-09-16 | Etherington Robert Dee | 奖励/授予 (A) | common stock | 15,244 | USD 3.28 | USD 50,000 | SEC 申报 ↗ |
| 2026-05-12 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 73,296 | USD 6.20 | USD 454,435 | SEC 申报 ↗ |
| 2026-05-11 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 22,177 | USD 6.75 | USD 149,695 | SEC 申报 ↗ |
| 2026-05-04 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 72,884 | USD 6.80 | USD 495,611 | SEC 申报 ↗ |
| 2026-05-01 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 5,795 | USD 6.01 | USD 34,828 | SEC 申报 ↗ |
| 2026-04-30 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 5,736 | USD 6.08 | USD 34,875 | SEC 申报 ↗ |
| 2026-04-29 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 12,170 | USD 5.63 | USD 68,517 | SEC 申报 ↗ |
| 2026-04-28 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 1,591 | USD 5.90 | USD 9,387 | SEC 申报 ↗ |
| 2026-04-21 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 61,345 | USD 6.14 | USD 376,658 | SEC 申报 ↗ |
| 2026-04-20 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 4,318 | USD 6.12 | USD 26,426 | SEC 申报 ↗ |
| 2026-04-17 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 25,040 | USD 6.43 | USD 161,007 | SEC 申报 ↗ |
| 2026-04-16 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 7,748 | USD 6.40 | USD 49,587 | SEC 申报 ↗ |
| 2026-04-15 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 6,374 | USD 6.48 | USD 41,304 | SEC 申报 ↗ |
| 2026-04-02 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 24,925 | USD 4.81 | USD 119,889 | SEC 申报 ↗ |
| 2026-04-01 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 4,278 | USD 4.97 | USD 21,262 | SEC 申报 ↗ |
| 2026-03-31 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 67,991 | USD 4.88 | USD 331,796 | SEC 申报 ↗ |
| 2026-03-30 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 15,536 | USD 5.10 | USD 79,234 | SEC 申报 ↗ |
| 2026-03-27 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 17,470 | USD 4.75 | USD 82,982 | SEC 申报 ↗ |
| 2026-03-26 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 5,319 | USD 5.40 | USD 28,723 | SEC 申报 ↗ |
| 2026-03-25 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 7,098 | USD 5.50 | USD 39,039 | SEC 申报 ↗ |
| 2026-03-24 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 5,492 | USD 5.78 | USD 31,744 | SEC 申报 ↗ |
| 2026-02-03 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 5,559 | USD 4.10 | USD 22,792 | SEC 申报 ↗ |
| 2026-02-02 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 3,800 | USD 4.04 | USD 15,352 | SEC 申报 ↗ |
| 2026-01-30 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 5,686 | USD 4.13 | USD 23,483 | SEC 申报 ↗ |
| 2026-01-29 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 15,284 | USD 4.32 | USD 66,027 | SEC 申报 ↗ |
| 2026-01-28 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 8,717 | USD 4.91 | USD 42,800 | SEC 申报 ↗ |
| 2026-01-27 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 4,139 | USD 5.08 | USD 21,026 | SEC 申报 ↗ |
| 2026-01-26 | Ugwumba Chidozie | 卖出 (S) | Common Stock | 6,418 | USD 5.02 | USD 32,218 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CLNN |
| CIK | 0001822791 |
| 行业 | Healthcare |
| 细分行业 | Packaged Foods Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 152 transaction lines from 2021-05-24 to 2026-09-16 44 P purchase lines · 82 S sale lines · 26 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.